Berkshire Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.64M | Buy |
3,955
+60
| +2% | +$60.8K | 0.16% | 74 |
|
|
2025
Q4 | $4.19M | Sell |
3,895
-916
| -19% | -$876K | 0.18% | 73 |
|
|
2025
Q3 | $3.67M | Buy |
4,811
+847
| +21% | +$630K | 0.16% | 79 |
|
|
2025
Q2 | $3.09M | Buy |
3,964
+50
| +1% | +$38.9K | 0.14% | 86 |
|
|
2025
Q1 | $2.94M | Sell |
3,914
-55
| -1% | -$45.8K | 0.14% | 87 |
|
|
2024
Q4 | $3.12M | Buy |
3,969
+83
| +2% | +$68.7K | 0.15% | 83 |
|
|
2024
Q3 | $3.52M | Hold |
3,886
| – | – | 0.18% | 75 |
|
|
2024
Q2 | $3.52M | Sell |
3,886
-100
| -3% | -$80K | 0.18% | 76 |
|
|
2024
Q1 | $3.1M | Sell |
3,986
-58
| -1% | -$41.3K | 0.16% | 74 |
|
|
2023
Q4 | $2.36M | Sell |
4,044
-7
| -0.2% | -$4.09K | 0.13% | 78 |
|
|
2023
Q3 | $2.18M | Sell |
4,051
-8
| -0.2% | -$4.12K | 0.14% | 79 |
|
|
2023
Q2 | $1.9M | Buy |
4,059
+58
| +1% | +$24.3K | 0.11% | 88 |
|
|
2023
Q1 | $1.37M | Buy |
+4,001
| New | +$1.35M | 0.08% | 97 |
|
|
2022
Q4 | – | Sell |
-3,791
| Closed | -$1.23M | – | 184 |
|
|
2022
Q3 | $1.23M | Sell |
3,791
-84
| -2% | -$26.6K | 0.09% | 96 |
|
|
2022
Q2 | $1.26M | Buy |
3,875
+76
| +2% | +$22.8K | 0.08% | 102 |
|
|
2022
Q1 | $1.09M | Buy |
3,799
+65
| +2% | +$16.7K | 0.07% | 100 |
|
|
2021
Q4 | $1.03M | Sell |
3,734
-26
| -0.7% | -$6.59K | 0.06% | 118 |
|
|
2021
Q3 | $869K | Buy |
3,760
+359
| +11% | +$88.6K | 0.06% | 124 |
|
|
2021
Q2 | $781K | Buy |
+3,401
| New | +$683K | 0.05% | 127 |
|
|
2021
Q1 | – | Sell |
-3,676
| Closed | -$621K | – | 233 |
|
|
2020
Q4 | $621K | Buy |
3,676
+391
| +12% | +$58.4K | 0.05% | 136 |
|
|
2020
Q3 | $486K | Hold |
3,285
| – | – | 0.05% | 112 |
|
|
2020
Q2 | $539K | Sell |
3,285
-270
| -8% | -$41.4K | 0.05% | 111 |
|
|
2020
Q1 | $493K | Sell |
3,555
-435
| -11% | -$59.8K | 0.05% | 132 |
|
|
2019
Q4 | $524K | Sell |
3,990
-7,605
| -66% | -$882K | 0.04% | 124 |
|
|
2019
Q3 | $1.3M | Buy |
11,595
+90
| +0.8% | +$10K | 0.11% | 97 |
|
|
2019
Q2 | $1.27M | Hold |
11,505
| – | – | 0.11% | 97 |
|
|
2019
Q1 | $1.49M | Hold |
11,505
| – | – | 0.13% | 93 |
|
|
2018
Q4 | $1.33M | Hold |
11,505
| – | – | 0.12% | 93 |
|
|
2018
Q3 | $1.24M | Sell |
11,505
-4,511
| -28% | -$451K | 0.1% | 98 |
|
|
2018
Q2 | $1.37M | Buy |
16,016
+716
| +5% | +$58.8K | 0.13% | 90 |
|
|
2018
Q1 | $1.18M | Buy |
15,300
+3,129
| +26% | +$252K | 0.11% | 96 |
|
|
2017
Q4 | $1.03M | Buy |
12,171
+7,533
| +162% | +$641K | 0.1% | 99 |
|
|
2017
Q3 | $397K | Buy |
4,638
+43
| +0.9% | +$3.53K | 0.04% | 141 |
|
|
2017
Q2 | $378K | Hold |
4,595
| – | – | 0.04% | 142 |
|
|
2017
Q1 | $386K | Hold |
4,595
| – | – | 0.05% | 143 |
|
|
2016
Q4 | $338K | Hold |
4,595
| – | – | 0.04% | 142 |
|
|
2016
Q3 | $369K | Hold |
4,595
| – | – | 0.05% | 136 |
|
|
2016
Q2 | $362K | Hold |
4,595
| – | – | 0.06% | 136 |
|
|
2016
Q1 | $331K | Hold |
4,595
| – | – | 0.05% | 129 |
|
|
2015
Q4 | $387K | Sell |
4,595
-155
| -3% | -$12.9K | 0.06% | 113 |
|
|
2015
Q3 | $398K | Sell |
4,750
-17,700
| -79% | -$1.49M | 0.07% | 105 |
|
|
2015
Q2 | $1.87M | Hold |
22,450
| – | – | 0.31% | 68 |
|
|
2015
Q1 | $1.63M | Buy |
22,450
+155
| +0.7% | +$11K | 0.27% | 71 |
|
|
2014
Q4 | $1.54M | Hold |
22,295
| – | – | 0.26% | 73 |
|
|
2014
Q3 | $1.45M | Hold |
22,295
| – | – | 0.27% | 74 |
|
|
2014
Q2 | $1.39M | Sell |
22,295
-4,733
| -18% | -$282K | 0.26% | 73 |
|
|
2014
Q1 | $1.59M | Sell |
27,028
-224
| -0.8% | -$12.5K | 0.31% | 68 |
|
|
2013
Q4 | $1.39M | Buy |
27,252
+513
| +2% | +$25.7K | 0.26% | 74 |
|
|
2013
Q3 | $1.35M | Hold |
26,739
| – | – | 0.32% | 70 |
|
|
2013
Q2 | $1.31M | Buy |
+26,739
| New | +$1.45M | 0.36% | 66 |
|
Other funds holding LLY
VCM
VPM
Berkshire Asset Management's LLY Position: Q1 2026 in Review
Berkshire Asset Management increased its Eli Lilly (LLY) stake by 1.5% in Q1 2026, buying an estimated $60.8K and bringing the position to 3,955 shares worth $3.64M. The position accounts for 0.16% of the portfolio, ranked #74.
Berkshire Asset Management first reported a position in LLY in Q2 2013 and has held it in 50 quarters since. The position peaked at $4.19M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Berkshire Asset Management held 3,955 shares of Eli Lilly worth $3.64M as of Q1 2026.
- Berkshire Asset Management bought 60 Eli Lilly shares in Q1 2026, an estimated $60.8K.
- Eli Lilly made up 0.16% of Berkshire Asset Management's portfolio in Q1 2026, its #74 holding.
- Berkshire Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 50 quarters since.
- Berkshire Asset Management's Eli Lilly position peaked at $4.19M in Q4 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Berkshire Asset Management's 13F filing for Q1 2026, filed 11 May 2026.